AmCad BioMed Corporation
4188
Rank in Stocks
#25283
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD)... AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Share Price
$0.42068553
Last synced: 2026-11-10
Market Cap
$26.64M
Change (1 day)
-1.43%
Change (1 year)
-17.62%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade AmCad BioMed Corporation (4188)
Category
Technology
EPS for AmCad BioMed Corporation (4188)
EPS as of June 2026 TTM: $-0.03
According to AmCad BioMed Corporation's latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.03, equal to its 2024 EPS of $-0.03.
EPS history for AmCad BioMed Corporation from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -14.67% |
| 2025 | $-0.03 | 4.48% |
| 2024 | $-0.03 | -1.11% |
| 2023 | $-0.03 | -17.63% |
| 2022 | $-0.03 | 90.17% |
| 2021 | $-0.02 | -27.31% |
| 2020 | $-0.02 | 0.42% |
| 2019 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $7.91 | -30,984.77% |
DE
|
|
| $1.66 | -6,584.38% |
CA
|
|
| $11.00 | -43,068.75% |
US
|
|
| $1.70 | -6,740.63% |
US
|
|
| $14.91 | -58,342.19% |
US
|
Questions about AmCad BioMed Corporation's earnings per share (EPS)
What is AmCad BioMed Corporation's earnings per share (EPS)?
AmCad BioMed Corporation's earnings per share (EPS) over the last twelve months is $-0.03, as of Jun 2026.
What was AmCad BioMed Corporation's earnings per share (EPS) in 2025?
In 2025, AmCad BioMed Corporation's earnings per share (EPS) was $-0.03, compared with $-0.03 in 2024.
How has AmCad BioMed Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, AmCad BioMed Corporation's earnings per share (EPS) was highest in 2021 ($-0.02) and lowest in 2025 ($-0.03).
How does AmCad BioMed Corporation's earnings per share (EPS) compare with similar companies?
AmCad BioMed Corporation's earnings per share (EPS) ($-0.03) is lower than that of all 5 similar companies listed above. The highest among them is AppLovin Corporation, with $14.91.